A Combination of Two Receptor Tyrosine Kinase Inhibitors, Canertinib and PHA665752 Compromises Ovarian Cancer Cell Growth in 3D Cell Models

Oncology and Therapy - Switzerland
doi 10.1007/s40487-016-0031-1
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Treatment of Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

2013English

Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Elderly Patients With Advanced Non-Small Cell Lung Cancer

Current Gerontology and Geriatrics Research
GerontologyGeriatrics
2010English

Estrogen Receptor Β1 Activation Accelerates Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

Oncology Reports
MedicineCancer ResearchOncology
2018English

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non–Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor

JAMA - Journal of the American Medical Association
Medicine
2014English

Protein Kinase A-Iα Subunit-Directed Antisense Inhibition of Ovarian Cancer Cell Growth: Crosstalk With Tyrosine Kinase Signaling Pathway

Oncogene
Cancer ResearchGeneticsMolecular Biology
1999English

Overcoming Resistance to First/Second Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and ALK Inhibitors in Oncogene-Addicted Advanced Non-Small Cell Lung Cancer

Therapeutic Advances in Medical Oncology
Oncology
2016English

Association of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment and EGFR Exon 19 Deletion With Frequency of the T790M Mutation in Non-Small Cell Lung Cancer Patients After Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

OncoTargets and Therapy
OncologyPharmacology
2019English

Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients Aged 80 Years or Older: A Retrospective Analysis

Molecular and Clinical Oncology
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy